GL1X · GenesisL1 explorer

Ligand · DDL

DDL · 2,6-dideoxy-beta-D-galactopyranose

DDL, 2,6-dideoxy-beta-D-galactopyranose (C6 H12 O4, 148.2 g/mol), in the MolNFT structures on GenesisL1: bound in 8 records (4 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands…

Component
DDL
Formula
C6 H12 O4
Class
sugar
Structures
8
PDB entries
4

Binding sites

DDL in 8 structures; the first of them:

  • 146D · Solution structure of the mithramycin dimer-DNA complex · DDL D2 · binds DA6
  • 1BP8 · 4:2:1 mithramycin:Mg++:d(ACCCGGGT)2 complex · DDL D2
  • 1CP8 · NMR structure of DNA (5'-D(TTGGCCAA)2-3') complexed with novel antitumor drug UCH9 · DDL C2 · binds DA7
  • 207D · Solution structure of mithramycin dimers bound to partially overlapping sites on DNA · DDL D2 · binds DA6
  • 146D · Solution structure of the mithramycin dimer-DNA complex · DDL D2 · binds DA6
  • 1BP8 · 4:2:1 MITHRAMYCIN:MG++:D(ACCCGGGT)2 complex · DDL D2
  • 1CP8 · NMR structure of DNA (5'-D(TTGGCCAA)2-3') complexed with novel antitumor drug UCH9 · DDL C2 · binds DA7
  • 207D · Solution structure of mithramycin dimers bound to partially overlapping sites on DNA · DDL D2 · binds DA6

Residues it binds most

DA 16, DG 2 (residue and the binding sites it lines).

Found with

  • DDA · beta-D-Olivopyranose
  • MG · Magnesium ion
  • MDA · 2,6-dideoxy-3-C-methyl-beta-D-ribo-hexopyranose
  • CRH · 1,2-hydro-1-oxy-3,4-hydro-3-(1-methoxy-2-oxy-3,4-dihydroxypentyl)-8,9-dihyroxy-7-methylanthracene
  • DXA · 1,2-hydro-1-oxy-3,4-hydro-3-(1-methoxy-2-oxy-3,4-dihydroxypentyl)-8,9-dihydroxy-7-(sec-butyl)-anthracene
  • DXB · 1,2-hydro-1-oxy-3,4-hydro-3-(1-methoxy-2-oxy-3,4-dihydroxypentyl)-8,9-dihydroxy-7-methyl-anthracene
  • DRI · 2,6-dideoxy-4-O-methyl-beta-D-glucopyranose

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.